Полиморфизмы генов цитокинов в механизмах развития воспалительного и язвенного поражений желудка
https://doi.org/10.31146/1682-8658-ecg-196-12-134-138
Аннотация
На сегодняшний день накоплено достаточно достоверных данных о вовлеченности различных генов цитокинов, продукты которых принимают непосредственное участие в процессах регуляции иммунного ответа при воспалительных процессах слизистой желудка. Однако, среди этих работ, исследования, посвященные генетическим механизмам формирования воспалительных и язвенных поражений желудка, малочисленны, а полученные данные противоречивы. Между тем, выявление предрасполагающих факторов, способных модулировать прогрессирование воспалительного процесса ведущего к развитию язв желудка имеет весьма важное значение в плане разработки их ранних прогностических критериев, и, вместе с этим, профилактических и лечебных стратегий.
Об авторах
Ф. Р. Исмоилова
Ташкентская медицинская академия
Узбекистан
Узбекистан
Исмоилова Фазилат Рустамовна, ассистент кафедры внутренних болезней № 2
100109, г. Ташкент, ул. Фаробий, 2
М. Т. Рустамова
Ташкентская медицинская академия
Узбекистан
Узбекистан
Рустамова Мамлакат Тулябаевна, доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней № 1
100109, г. Ташкент, ул. Фаробий, 2
Список литературы
1. Amieva M., Peek R. M., Jr Pathobiology of Helicobacter pylori-Induced Gastric Cancer. Gastroenterology. 2016 Jan;150(1):64–78. doi:10.1053/j.gastro.2015.09.004.
2. Chen M.Y., He C. Y., Meng X., Yuan Y. Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer. WJG. 2013 Jul 14;19(26):4242–51. doi:10.3748/wjg.v19.i26.4242.
3. Sahara S., Sugimoto M., Vilaichone R. K., et al. Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis. BMC Infect Dis. 2012 Sep 21;12:223. doi:10.1186/1471–2334–12–223.
4. Ter Horst R., Jaeger M., Smeekens S. P., Oosting M., et al. Host and environmental factors influencing individual human cytokine responses. Cell. 2016; 167(4):1111e-24e. doi:10.1016/j.cell.2016.10.018.
5. Liu Y., Xu Y., Wang Y., Yao Y., Yang J. Associations between interleukin gene polymorphisms and the risk of gastric cancer: A meta-analysis. Clin Exp Pharmacol Physiol. 2018 Dec;45(12):1236–1244. doi:10.1111/1440–1681.13021.
6. Zhang X.S., Tegtmeyer N., Traube L., et al. A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions. PLoS Pathog. 2015 Feb 3;11(2): e1004621. doi:10.1371/journal.ppat.1004621.
7. Matsunari O., Shiota S., Suzuki R., et al. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol. 2012 Mar;50(3):876–83. doi:10.1128/JCM.05562–11.
8. Mift ahussurur M., Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2015;9(12):1535–47. doi:10.1586/17474124.2015.1095089.
9. Ramis I.B., Vianna J. S., Gonçalves C. V., von Groll A., Dellagostin O. A., da Silva P. E.A. Polymorphisms of the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter pylori. J Microbiol Immunol Infect. 2017 Apr;50(2):153–159. doi:10.1016/j.jmii.2015.03.002.
10. Toller I.M., Neelsen K. J., Steger M., et al. Carcinogenic bacterial patho-gen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Nat Acad Sci. USA. 2011 Sep 6;108(36):14944–9. doi:10.1073/pnas.1100959108.
11. Shiota S., Watada M., Matsunari O., et al. Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS ONE. 2012;7(1): e30354. doi:10.1371/journal.pone.0030354.
12. Kang J.M., Kim N., Lee D. H., et al. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol. 2009 May-Jun;43(5):420–8. doi:10.1097/MCG.0b013e318178d1d3.
13. de Oliveira J. G., Rossi A. F.T., Nizato D. M., et al. Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer. Tumor Biol. 2015 Dec;36(12):9159–70. doi:10.1007/s13277–015–3593-x.
14. Bockerstett K.A., DiPaolo R. J. Regulation of Gastric Carcinogenesis by Inflammatory Cytokines. Cell Mol Gastroenterol. Hepatol. 2017 Mar 14;4(1):47–53. doi:10.1016/j.jcmgh.2017.03.005.
15. Li Z.W., Wu Y., Sun Y., et al. Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia. World J Gastroenterol. 2010 Apr 14;16(14):1788–94. doi:10.3748/wjg.v16.i14.1788.
16. Stubljar D., Jeverica S., Jukic T. The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection. Radiol Oncol. 2015 Aug 21;49(3):256–64. doi:10.2478/raon-2014–0041.
17. Kawai M., Furuta Y., Yahara K., et al. Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes. BMC microbial. 2011 May 16;11:104. doi:10.1186/1471–2180–11–104.
18. Spoto B., Mattace-Raso F., Sijbrands E., et al. Association of IL-6 and a functional polymorphism in the IL-6 Gene with cardiovascular events in patients with CKD. Clin J Am Soc Nephrol. 2014;10:232–40. doi:10.2215/CJN.07000714.
19. Pormohammad A., Mohtavinejad N., Gholizadeh P., et al. Global estimate of gastric cancer in Helicobacter pyloriinfected population: A systematic review and meta-analysis. J Cell Physiol. 2019 Feb;234(2):1208–1218. doi:10.1002/jcp.27114.
20. Kodaman N., Pazos A., Schneider B. G., et al. Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad. Sci. U S A. 2014 Jan 28;111(4):1455–60. doi:10.1073/pnas.1318093111.
21. Miwa K., Okazaki S., Sakaguchi M., Mochizuki H., Kitagawa K. Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia. Eur J Neurol. 2016; 23(3):656–63. doi:10.1111/ene.12921.
22. Szkaradkiewicz A., Karpinski T. M., Drews M., et al. (2010) Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer. J Biomed Biotechnol. 2010;2010:901564. doi:10.1155/2010/901564.
23. Zhuang W., Wu X. T., Zhou Y., et al. Interleukin 10–592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci. 2010 Jun;55(6):1525–32. doi:10.1007/s10620–009–0922–1.
24. Mommersteeg M.C., Yu J., Peppelenbosch M. P., Fuhler G. M. Genetic host factors in Helicobacter pyloriinduced carcinogenesis: Emerging new paradigms. Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):42–52. doi:10.1016/j.bbcan.2017.11.003.
25. Puzianowska- Kuźnicka M., Owczarz M., WieczorowskaTobis K., et al. Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing. 2016 Jun 3;13:21. doi: 10.1186/s12979–016–0076-x.
26. Leja M., Wex T., Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis. 2012;30(3):268–76. doi:10.1159/000336990.
27. Sampaio A. M., Balseiro S. C., Silva M. R., et al. Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population. GE Port J Gastroenterol. 2015 Jul 4;22(4):143–152. doi:10.1016/j.jpge.2015.04.001.
28. Davies R., Choy E. Clinical experience of IL-6 blockade in rheumatic diseases – implications on IL-6 biology and disease pathogenesis. Semin Immunol. 2014; 26:97–104. doi:10.1016/j.smim.-2013.12.002.
29. Sugimoto M., Yamaoka Y., Furuta T. Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol. 2010 Mar 14;16(10):1188–200. doi:10.3748/wjg.v16.i10.1188.
30. Kumar S., Kumari N., Mittal R. D., Mohindra S., Ghoshal U. C. Association between pro-(IL-8) and antiinfl ammatory (IL-10) cytokine variants and their serum levels and H. pylori-related gastric carcinogenesis in northern India. Meta Gene. 2015 Aug 26;6:9–16. doi:10.1016/j.mgene.2015.07.008.
31. Assis S., Marques C. R., Silva T. M., Costa R. S., AlcantaraNeves N.M., Barreto M. L., et al. IL10 single nucleotide polymorphisms are related to upregulation of constitutive IL-10 production and susceptibility to Helicobacter pylori infection. Helicobacter. 2014 Jun;19(3):168–73. doi:10.1111/hel.12119.
32. Cheng H. H., Chang C. S., Wang H. J., Wang W. C. Interleukin-1beta and –10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients. J Gastroenterol. Hepatol. 2010 Aug;25(8):1443–51. doi:10.1111/j.1440–1746.2010.06310.x.
33. Chiurillo M. A. Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries. World J Gastroenterol. 2014 Apr 28;20(16):4503–15. doi:10.3748/wjg.v20.i16.4503.
34. Akdogan R. A., Ozgur O., Gucuyeter S., et al. A pilot study of Helicobacter pylori genotypes and cytokine gene polymorphisms in reflux oesophagitis and peptic ulcer disease. Bratisl. Lek. Listy. 2014;115(4):221–8. doi:10.4149/bll_2014_046.
35. de Brito B. B., da Silva F. A.F., de Melo F. F. Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis. World J Clin. Oncol. 2018 Sep 14;9(5):83–89. doi:10.5306/wjco.v9.i5.83.
36. Qu X., Tang Y., Hua S. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Front Immunol. 2018 Mar 20;9:563. doi:10.3389/fimmu.2018.00563.
37. Lio D., Scola L., Crivello A., et al. Inflammation, genetics and longevity: further studies on the prospective effects in men of IL-10–1082 promoter SNP and its interaction with TNF-alpha-308 promoter SNP. J Med Genet. 2003 Apr;40(4):296–9. doi:10.1136/jmg.40.4.296.
38. Kim J., Cho Y. A., Choi I. J., et al. Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One. 2012;7(1): e29643. doi:10.1371/journal.pone.0029643.
39. Liu S., Liu J. W., Sun L. P., et al. Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. J Int Med Res. 2018 Dec;46(12):5155–5166. doi:10.1177/0300060518792785.
40. Anca Negovan, Mihaela Iancu, Emőke Fülöp, and Claudia Bănescu Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J. Gastroenterol. 2019 Aug 14;25(30):4105–4124. doi:10.3748/wjg.v25.i30.4105.
41. Graham D. Y. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015 Apr;148(4):719–31.e3. doi:10.1053/j.gastro.2015.01.040.
42. Hooi J. K.Y, Lai W. Y., Ng W. K., Suen M. M.Y., et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 Aug;153(2):420–429. doi:10.1053/j.gastro.2017.04.022.
Рецензия
Для цитирования:
Исмоилова Ф.Р., Рустамова М.Т. Полиморфизмы генов цитокинов в механизмах развития воспалительного и язвенного поражений желудка. Экспериментальная и клиническая гастроэнтерология. 2021;(12):134-138. https://doi.org/10.31146/1682-8658-ecg-196-12-134-138
For citation:
Ismoilova F.R., Rustamova M.T. Polymorphisms of cytokine genes in the mechanisms of development of inflammatory and ultrasonic gastric damage. Experimental and Clinical Gastroenterology. 2021;(12):134-138. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-196-12-134-138
Просмотров:
330
Послать статью по эл. почте 